imatinib,nilotinib
inhibikase,novartis
['leusm', 'nilotinib', '#mpn', 'mpnsm', 'cml', 'imatinib']
#asco22 #mpnsm #leusm attalah: no diff in os between any tki in fl for cml. nilotinib and dasatinib reduce progression to ap/bp vs imatinib, but effect is small. matching se profile of specific tkis most important for selecting therapy for patients (4th slide helpful reference) 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)